OSU Center Lands $11.3M for Thyroid Cancer Risk Studies, Resource Cores | GenomeWeb

NEW YORK (GenomeWeb News) – Investigators at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have reeled in an $11.3 million grant from the National Cancer Institute to pursue genome-focused thyroid cancer studies and to fund shared core resources.

Specifically, the NCI funding will support a study that launched in 2008 called "Genetic and Signaling Pathways in Epithelial Thyroid Cancer," which has four integrated components.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.